000 01213 a2200337 4500
005 20250514040034.0
264 0 _c20020806
008 200208s 0 0 eng d
022 _a1473-7140
024 7 _a10.1586/14737140.2.2.143
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTejada-Berges, T
245 0 0 _aCaelyx/Doxil for the treatment of metastatic ovarian and breast cancer.
_h[electronic resource]
260 _bExpert review of anticancer therapy
_cApr 2002
300 _a143-50 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aClinical Trials as Topic
_xmethods
650 0 4 _aDoxorubicin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aNeoplasm Recurrence, Local
_xdrug therapy
650 0 4 _aOvarian Neoplasms
_xdrug therapy
700 1 _aGranai, C O
700 1 _aGordinier, M
700 1 _aGajewski, W
773 0 _tExpert review of anticancer therapy
_gvol. 2
_gno. 2
_gp. 143-50
856 4 0 _uhttps://doi.org/10.1586/14737140.2.2.143
_zAvailable from publisher's website
999 _c12004481
_d12004481